Male androgenetic alopecia

Hair, Hair Growth and Hair Disorders

Volumn , Issue , 2008, Pages 159-170

  Messenger, Andrew ^a  

^a ROYAL HALLAMSHIRE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 84892297647     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1007/978-3-540-46911-7_9     Document Type: Chapter

References (69)

1. Akgun S, Ertel NH, Imperato-McGinley J et al (1986) Familial male pseudohermaphroditism due to 5-Alphareductase deficiency in a Turkish village. Am J Med; 81: 267-274.
2. Arca E, Acikgoz G, Tastan HB et al (2004) An open, randomized, comparative study of oral finasteride and 5% topical minoxidil in male androgenetic alopecia. Dermatology; 209: 117-125.
3. Asada Y, Sonoda T, Ojiro M et al (2001) 5 alpha-reductase type 2 is constitutively expressed in the dermal papilla and connective tissue sheath of the hair follicle in vivo but not during culture in vitro. J Clin Endocrinol Metab; 86: 2875-2880.
4. Bang HJ, Yang YJ, Lho DS et al (2004) Comparative studies on level of androgens in hair and plasma with premature male-pattern baldness. J Dermatol Sci; 34: 11-16.
5. Birch MP, Messenger AG (2001) Genetic factors predispose to balding and non-balding in men. Eur J Dermatol; 11: 309-314.
6. Carey AH, Chan KL, Short F et al (1993) Evidence for a single gene effect causing polycystic ovaries and male pattern baldness. Clin Endocrinol (Oxf); 38: 653-658.
7. Carey AH, Waterworth D, Patel K et al (1994) Polycystic ovaries and premature male pattern baldness are associated with one allele of the steroid metabolism gene CYP17. Hum Mol Genet; 3: 1873-1876.
8. Cash TF (1999) The psychosocial consequences of androgenetic alopecia: A review of the research literature. Br J Dermatol; 141: 398-405.
9. Courtois M, Loussouarn G, Hourseau C (1995) Aging and hair cycles. Br J Dermatol; 132: 86-93.
10. Demark-Wahnefried W, Lesko SM, Conaway MR et al (1997) Serum androgens: Associations with prostate cancer risk and hair patterning. J Androl; 18: 495-500.
11. Diani AR, Mulholland MJ, Shull KL et al (1992) Hair growth effects of oral administration of finasteride, a steroid 5 alpha-reductase inhibitor, alone and in combination with topical minoxidil in the balding stumptail macaque. J Clin Endocrinol Metab; 74: 345-350.
12. Drake L, Hordinsky M, Fiedler V et al (1999) The effects of finasteride on scalp skin and serum androgen levels in men with androgenetic alopecia. J Am Acad Dermatol; 41: 550-554.
13. Elliott K, Stephenson TJ, Messenger AG (1999) Differences in hair follicle dermal papilla volume are due to extracellular matrix volume and cell number: implications for the control of hair follicle size and androgen responses. J Invest Dermatol; 113: 873-877.
14. Ellis JA, Stebbing M, Harrap SB (1998) Genetic analysis of male pattern baldness and the 5a-reductase genes. J Invest Dermatol; 110: 849-853.
15. Ellis JA, Stebbing M, Harrap SB (1999) Insulin gene polymorphism and premature male pattern baldness in the general population. Clin Sci; 96: 659-662.
16. Ellis JA, Stebbing M, Harrap SB (2001) Male pattern baldness is not associated with established cardiovascular risk factors in the general population. Clin Sci; 100: 401-404.
17. Ellis JA, Stebbing M, Harrap SB (2001) Polymorphism of the androgen receptor gene is associated with male pattern baldness. J Invest Dermatol; 116: 452-455.
18. Gutersohn T, Scheidegger EP (2005) Is baldness bad for the heart? Dermatology; 211: 72-74.
19. Hamilton JB (1942) Male hormone stimulation is prerequisite and an incitant in common baldness. Am J Anat; 71: 451-480.
20. Hamilton JB (1951) Patterned loss of hair in man: Types and incidence. Ann N Y Acad Sci; 53: 708-728.
21. Harris H (1946) The inheritance of premature baldness in men. Ann Eugenics; 13: 172-181.
22. Hayakawa K, Shimizu T, Ohba Y et al (1998) Intrapair differences of physical aging and longevity in identical twins. Acta Genet Med Gemellol (Roma); 41: 177-185.
23. Hayes VM, Severi G, Eggleton SA et al (2005) The E211 G>A androgen receptor polymorphism is associated with a decreased risk of metastatic prostate cancer and androgenetic alopecia. Cancer Epidemiol Biomarkers Prev; 14: 993-996.
24. Herrera CR, D'Agostino RB, Gerstman BB et al (1995) Baldness and coronary heart disease rates in men from the Framingham Study. Am J Epidemiol; 142: 828-833.
25. Hillmer AM, Hanneken S, Ritzmann S et al (2005) Genetic variation in the human androgen receptor gene is the major determinant of common early-onset androgenetic alopecia. Am J Hum Genet; 77: 140-148.
26. Hsieh CC, Thanos A, Mitropoulos D et al (1999) Risk factors for prostate cancer: A case-control study in Greece. Int J Cancer; 80: 699-703.
27. Imperato-McGinley J (2002) 5alpha-reductase-2 deficiency and complete androgen insensitivity: lessons from nature. Adv Exp Med Biol; 511: 121-131.
28. Imperato-McGinley J, Miller M, Wilson JD et al (1991) A cluster of male pseudohermaphrodites with 5 alphareductase deficiency in Papua New Guinea. Clin Endocrinol (Oxf); 34: 293-298.
29. Inui S, Fukuzato Y, Nakajima T et al (2002) Androgeninducible TGF-beta1 from balding dermal papilla cells inhibits epithelial cell growth: A clue to understand paradoxical effects of androgen on human hair growth. FASEB J; 16: 1967-1969.
30. Itami S, Kurata S, Sonoda T et al (1991) Characterization of 5 alpha-reductase in cultured human dermal papilla cells from beard and occipital scalp hair. J Invest Dermatol; 96: 57-60.
31. Itami S, Kurata S, Takayasu S (1995) Androgen induction of follicular epithelial cell growth is mediated via insulin-like growth factor-I from dermal papilla cells. Biochem Biophys Res Commun; 212: 988-994.
32. Jaworsky C, Kligman AM, Murphy GF (1992) Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis. Br J Dermatol; 127: 239-246.
33. Jenkins EP, Hsieh CL, Milatovich A et al (1991) Characterization and chromosomal mapping of a human steroid 5 alpha-reductase gene and pseudogene and mapping of the mouse homologue. Genomics; 11: 1102-1112.
34. Kaufman KD, Olsen EA, Whiting D et al (1998) Finasteride in the treatment of men with androgenetic alopecia. J Am Acad Dermatol; 39: 578-589.
35. Kligman AM (1988) The comparative histopathology of male-pattern baldness and senescent baldness. Clin Dermatol; 6: 108-118.
36. Knussmann R, Christiansen K, Kannmacher J (1992) Relations between sex hormone level and characters of hair and skin in healthy young men. Am J Phys Anthropol; 88: 59-67.
37. Kuster W, Happle R (1984) The inheritance of common baldness: Two B or not two B? J Am Acad Dermatol; 11: 921-926.
38. Lee HJ, Chang C (2003) Recent advances in androgen receptor action. Cell Mol Life Sci; 60: 1613-1622.
39. Lotufo PA, Chae CU, Ajani UA et al (2000) Male pattern baldness and coronary heart disease: The Physicians' Health Study. Arch Intern Med; 160: 165-171.
40. Maffei C, Fossati A, Rinaldi F et al (1994) Personality disorders and psychopathologic symptoms in patients with androgenetic alopecia. Arch Dermatol; 130: 868-872.
41. Matilainen VA, Makinen PK, Keinanen-Kiukaanniemi SM (2001) Early onset of androgenetic alopecia associated with early severe coronary heart disease: A population- based, case-control study. J Cardiovasc Risk; 8: 147-151.
42. Messenger AG, Rundegren J (2004) Minoxidil: Mechanisms of action on hair growth. Br J Dermatol; 150: 186-194.
43. Nordstrom REA (1979) Synchronous balding of scalp and hair-bearing grafts of scalp transplanted to the skin of the arm in male pattern baldness. Acta Derm Venereol; 59: 266-268.
44. Norwood OT (1975) Male pattern baldness: classification and incidence. South Med J; 68: 1359-1365.
45. Nyholt DR, Gillespie NA, Heath AC et al (2003) Genetic basis of male pattern balding. J Invest Dermatol; 121: 1561-1564.
46. Oliver RF (1970) The induction of hair follicle formation in the adult hooded rat by vibrissa dermal papillae. J Embryol Exp Morphol; 23: 219-236.
47. Olsen EA, Weiner MS, Amara IA et al (1990) Five-year follow-up of men with androgenetic alopecia treated with topical minoxidil. J Am Acad Dermatol; 22: 643-646.
48. Olsen EA, Dunlap FE, Funicella T et al (2002) A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. J Am Acad Dermatol; 47: 377-385.
49. Olsen EA, Messenger AG, Shapiro J et al (2005) Evaluation and treatment of male and female pattern hair loss. J Am Acad Dermatol; 52: 301-311.
50. Orentreich N (1959) Autografts in alopecias and other selected dermatological conditions. Ann N Y Acad Sci; 83: 463-479.
51. Osborn D (1916) Inheritance of baldness. J Hered; 7: 347-355.
52. Paik JH, Yoon JB, Sim WY et al (2001) The prevalence and types of androgenetic alopecia in Korean men and women. Br J Dermatol; 145: 95-99.
53. Patterson MN, McPhaul MJ, Hughes IA (1994) Androgen insensitivity syndrome. Baillieres Clin Endocrinol Metab; 8: 379-404.
54. Price VH, Menefee E, Strauss PC (1999) Changes in hair weight and hair count in men with androgenetic alopecia, after application of 5% and 2% topical minoxidil, placebo or no treatment. J Am Acad Dermatol; 41: 717-721.
55. Randall VA, Hibberts NA, Thornton MJ et al (2000) The hair follicle: A paradoxical androgen target organ. Horm Res; 54: 243-250.
56. Rexbye H, Petersen I, Iachina M et al (2005) Hair loss among elderly men: Etiology and impact on perceived age. J Gerontol A Biol Sci Med Sci; 60: 1077-1082.
57. Rittmaster RS, Uno H, Povar ML et al (1987) The effects of N, N-diethyl-4-methyl-3-oxo-4-Aza-5a-Androstane- 17b-carboxamide, a 5a-reductase inhibitor and antiandrogen, on the development of baldness in the stumptail macaque. J Clin Endocrinol Metab; 65: 188-192.
58. Setty LR (1970) Hair patterns of scalp of white and Negro males. Am J Phys Anthropol; 33: 49-55.
59. Shapiro J, Kaufman KD (2003) Use of finasteride in the treatment of men with androgenetic alopecia (male pattern hair loss). J Investigat Dermatol Symp Proc 8: 20-23.
60. Sigelman L, Dawson A, Nitz M et al (1990) Hair loss and electability: The bald truth. J Nonverbal Behav; 14: 269-283.
61. Smith MA, Wells RS (1964) Male-Type alopecia, alopecia areata, and normal hair in women. Arch Dermatol; 89: 155-158.
62. Sreekumar GP, Pardinas J, Wong CQ et al (1999) Serum androgens and genetic linkage analysis in early onset androgenetic alopecia. J Invest Dermatol; 113: 277-279.
63. Thigpen AE, Davis DL, Milatovich A et al (1992) Molecular genetics of steroid 5 alpha-reductase 2 deficiency. J Clin Invest; 90: 799-809.
64. Thigpen AE, Silver RI, Guileyardo JM et al (1993) Tissue distribution and ontogeny of steroid 5 alpha-reductase isozyme expression. J Clin Invest; 92: 903-910.
65. Thompson IM, Goodman PJ, Tangen CM et al (2003) The influence of finasteride on the development of prostate cancer. N Engl J Med; 349: 215-224.
66. Van Scott EJ, Ekel TM (1958) Geometric relationships between the matrix of the hair bulb and its dermal papilla in normal and alopecic scalp. J Invest Dermatol; 31: 281-287.
67. West PM, Packer C (2002) Sexual selection, temperature, and the lion's mane. Science; 297: 1339-1343.
68. Whiting DA (1993) Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia. J Am Acad Dermatol; 28: 755-763.
69. Zappacosta AR (1980) Reversal of baldness in patient receiving minoxidil for hypertension. N Engl J Med; 303: 1480-1170.